IASO Biotechnology has received US Food and Drug Administration clearance for the Investigational New Drug application o...
Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
For children born with cleft lip and palate, repairing gaps in the jawbone often means waiting until they are 10 to 12 y...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
Scientists from Nanyang Technological University (NTU), Singapore have developed microscopic peptide droplets that deliv...
Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran ...
Researchers from the National University of Singapore (NUS) Medicine and China's Tianjin Medical University General Hosp...
Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have sign...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
The Obesity and Metabolic Surgery Society of India and the Endocrine Society of India have issued their first joint cons...
As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
IASO Biotechnology has completed its acquisition of Singapore-based MediSix Therapeutics, expanding its international ce...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
Scientists at Northwestern University have found that tissue environments surrounding persistent viral reservoirs share ...
The US Food and Drug Administration has approved Moderna’s mFlusiva seasonal influenza vaccine for adults aged 50 ...
A Phase III clinical trial has found that adding high-dose vitamin D3 to chemotherapy and bevacizumab does not improve p...
Researchers at Stony Brook Cancer Center have developed an experimental RNA-based therapy that reduced non-small cell lu...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
